Benefit of paclitaxel in estrogen receptor-negative versus estrogen receptor-positive early breast cancer - Reply

被引：3
作者：
Henderson, IC [1 ]
Norton, L
Berry, DA
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[3] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2003年 / 21卷 / 23期
关键词：
D O I：
10.1200/JCO.2003.99.185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4465 / 4466
页数：2
相关论文
共 50 条
  • [11] Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
    Ximena García
    Andrés Elía
    Lucrecia Galizzi
    María May
    Eunice Spengler
    Paula Martínez Vázquez
    Javier Burruchaga
    Hugo Gass
    Claudia Lanari
    Caroline A. Lamb
    [J]. Breast Cancer Research and Treatment, 2020, 180 : 257 - 263
  • [12] Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
    Niemeier, Leo A.
    Dabbs, David J.
    Beriwal, Sushil
    Striebel, Joan M.
    Bhargava, Rohit
    [J]. MODERN PATHOLOGY, 2010, 23 (02) : 205 - 212
  • [13] GATA3 Is a Marker of Estrogen Receptor-Positive but Not Estrogen Receptor-Negative Breast Cancers
    Piscuoglio, S.
    Wen, Y. H.
    Martelotto, L. G.
    Rocco, E. Guerini
    Akram, M.
    Jungbluth, A. A.
    Brogi, E.
    Weigelt, B.
    Reis-Filho, J. S.
    [J]. MODERN PATHOLOGY, 2014, 27 : 76A - 76A
  • [14] GATA3 Is a Marker of Estrogen Receptor-Positive but Not Estrogen Receptor-Negative Breast Cancers
    Piscuoglio, S.
    Wen, Y. H.
    Martelotto, L. G.
    Rocco, E. Guerini
    Akram, M.
    Jungbluth, A. A.
    Brogi, E.
    Weigelt, B.
    Reis-Filho, J. S.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 76A - 76A
  • [15] Sex Hormone Levels and Risks of Estrogen Receptor-Negative and Estrogen Receptor-Positive Breast Cancers
    Farhat, Ghada N.
    Cummings, Steven R.
    Chlebowski, Rowan T.
    Parimi, Neeta
    Cauley, Jane A.
    Rohan, Thomas E.
    Huang, Alison J.
    Vitolins, Mara
    Hubbell, F. Allan
    Manson, JoAnn E.
    Cochrane, Barbara B.
    Lane, Dorothy S.
    Lee, Jennifer S.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (07): : 562 - 570
  • [16] Does estrogen receptor-negative/progesterone receptor-positive breast carcinoma exist?
    De Maeyer, Leen
    Van Limbergen, Erik
    De Nys, Katelijne
    Moerman, Philippe
    Pochet, Nathalie
    Hendrickx, Wouter
    Wildiers, Hans
    Paridaens, Robert
    Smeets, Ann
    Christiaens, Marie-Rose
    Vergote, Ignace
    Leunen, Karin
    Amant, Frederic
    Neven, Patrick
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) : 335 - 336
  • [17] Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI?
    Chen, J. -H.
    Hsu, F. -T.
    Shih, H. -N.
    Hsu, C. -C.
    Chang, D.
    Nie, K.
    Nalcioglu, O.
    Su, M. -Y.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (08) : 1447 - 1449
  • [18] The Clinicopathologic Characteristics and Clinical Outcomes of Estrogen Receptor-Negative and Progesterone Receptor-Positive Breast Cancer
    Kang, S.
    Jeon, Y.
    Kim, C.
    Cho, Y.
    Lee, S.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 724S - 725S
  • [19] Genes Dysregulated to Different Extent or Oppositely in Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancers
    Zhou, Xianxiao
    Shi, Tongwei
    Li, Bailiang
    Zhang, Yuannv
    Shen, Xiaopei
    Li, Hongdong
    Hong, Guini
    Liu, Chunyang
    Guo, Zheng
    [J]. PLOS ONE, 2013, 8 (07):
  • [20] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
    Zheng, Hongjuan
    Ge, Chenyang
    Lin, Haiping
    Wu, Lunpo
    Wang, Qinghua
    Zhou, Shishi
    Tang, Wanfen
    Zhang, Xia
    Jin, Xiayun
    Xu, Xifeng
    Hong, Zhongwu
    Fu, Jianfei
    Du, Jinlin
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (07) : 1145 - 1153
12345